Cellular proliferation in canine cutaneous mast cell tumors: Associations with c-KIT and its role in prognostication

Veterinary Pathology

Volumn 44, Issue 3, 2007, Pages 298-308

  Webster, J D ^a   Yuzbasiyan Gurkan, V ^a,b   Miller, R A ^a   Kaneene, J B ^a   Kiupel, M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

AgNOR; c KIT; Canine; Ki67; Mast cell tumors; PCNA; Prognostic markers; Proliferation

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLINE; NUCLEAR PROTEIN; NUCLEOLAR ORGANIZER REGION ASSOCIATED PROTEINS; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; CELL PROLIFERATION; DOG; DOG DISEASE; METABOLISM; PATHOLOGY; PROGNOSIS; URTICARIA PIGMENTOSA;

ANIMALS; ANTIGENS, NUCLEAR; CELL PROLIFERATION; DOG DISEASES; DOGS; MASTOCYTOSIS, CUTANEOUS; NUCLEAR PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-KIT;

CANIS FAMILIARIS;

EID: 34249282375     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.44-3-298     Document Type: Article

References (71)

1. Abadie JJ, Amardeilh MA, Delverdier ME: Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 215:1629-1634, 1999
2. Bostock DE: The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 14:27-41, 1973
3. Bostock DE, Crocker J, Harris K, Smith P: Nucleolar organiser regions as indicators of postsurgical prognosis in canine spontaneous mast cell tumours. Br J Cancer 59:915-918, 1989
4. Bravo R, Celis JE: A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol 84:795-802, 1980
5. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326:515-517, 1987
6. Bravo R, Macdonald-Bravo H: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105:1549-1554, 1987
7. Brodey RS: Canine and feline neoplasia. Adv Vet Sci Comp Med 14:309-354, 1970
8. Brugal G: Interpretation of proliferation markers. Comp Cytol Histol Labor 234-239, 1994
9. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM: The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 149:599-608, 1992
10. Dastych J, Metcalfe DD: Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 152:213-219, 1994
11. Derenzini M: The AgNORs. Micron 31:117-120, 2000
12. Derenzini M, Pession A, Trere D: Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest 63:137-140, 1990
13. Downing S, Chien MB, Kass PH, Moore PE, London CA: Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. Am J Vet Res 63:1718-1723, 2002
14. Elias JM: Cell proliferation indexes: a biomarker in solid tumors. Biotech Histochem 72:78-85, 1997
15. Finnie JW, Bostock DE: Skin neoplasia in dogs. Aust Vet J 55:602-604, 1979
16. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715, 1984
17. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70, 2000
18. Hilska M, Collan YU, Lane VJO, Kossi J, Hirsimaki P, Laato M, Roberts PJ: The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer. Dis Colon Rectum 48:2197-2208, 2005
19. Hofstadter F, Knuchel R, Ruschoff J: Cell proliferation assessment in oncology. Virchows Arch 427:323-341, 1995
20. Hung LC, Pong VF, Cheng CR, Wong FI, Chu RM: An improved system for quantifying AgNOR and PCNA in canine tumors. Anticancer Res 20:3273-3280, 2000
21. Jones CL, Grahn RA, Chien MB, Lyons LA, London CA: Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis. J Vet Diagn Invest 16:95-100, 2004
22. Kiupel M, Teske E, Bostock D: Prognostic factors for treated canine malignant lymphoma. Vet Pathol 36:292-300, 1999
23. Kiupel M, Webster JD, Bailey KL, Best S, DeLay J, Detrisac CJ, Gamble D, Ginn PE, Goldschmidt MH, Hendrick MJ, Howerth EW, Janovitz EB, Lenz SD, Lipscomb T, Miller E, Misdorp W, Moroff S, Neyens I, O'Toole D, Ramos-Vara J, Scase TJ, Schulman Y, Smith K, Snyder P, Southorn E, Stedman NL, Steficek BA, Stromberg PC, Valli VE, Weisbrode SE, Yager J, Kaneene JB: Microscopic grading of canine cutaneous mast cell tumors: a multi-institutional review. Vet Pathol 41:576, 2004
24. Kravis LD, Vail DM, Kisseberth WC, Ogilvie GK, Volk LM: Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs. J Am Vet Med Assoc 209:1418- 1420, 1996
25. Linden MD, Torres FX, Kubus J, Zarbo RJ: Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol 97:S4-S13, 1992
26. Lohr CV, Teifke JP, Failing K, Weiss E: Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Vet Pathol 34:212-221, 1997
27. London CA, Galli SJ, Yuuki T, Hu ZQ, Helfand SC, Geissler EN: Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol 27:689-697, 1999
28. Ma Y, Longley BJ, Wang X, Blount JL, Langley K, Caughey GH: Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms. J Invest Dermatol 112:165-170, 1999
29. Madewell BR: Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications. J Vet Intern Med 15:334-340, 2001
30. Maga G, Hubscher U: Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 116:3051-3060, 2003
31. Martin H, Hufnagel P, Beil M: Nucleolar organizer region-associated proteins in cancer cells: quantitative investigations on gliomas, meningiomas, urinary bladder carcinomas and pleural lesions. Analyt Quant Cytol Histol 14:312-319, 1992
32. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR: The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79:958-963, 1992
33. Misdorp W: Mast cells and canine mast cell tumours: a review. Vet Q 26:156-169, 2004
34. Mukaratirwa S: Prognostic and predictive markers in canine tumours: rationale and relevance - a review. Vet Q 27:52-64, 2005
35. Nocka K, Buck J, Levi E, Besmer P: Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 9:3287-3294, 1990
36. Northrup NC, Harmon BG, Gieger TL, Brown CA, Carmichael KP, Garcia A, Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Cheng AL, Howerth EW: Variation among pathologists in histologic grading of canine cutaneous mast cell tumors. J Vet Diagn Invest 17:245-248, 2005
37. Northrup NC, Howerth EW, Harmon BG, Brown CA, Carmicheal KP, Garcia AP, Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Gieger TL: Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference. J Vet Diagn Invest 17:561-564, 2005
38. Ofner D, Hittmair A, Marth C, Ofner C, Totsch M, Daxenbichler G, Mikuz G, Margreiter R, Schmid KW: Relationship between quantity of silver stained nucleolar organizer regions associated proteins (AgNORs) and population doubling time in ten breast cancer cell lines. Pathol Res Pract 188:742-746, 1992
39. Ogura S, Abe S, Sukoh N, Kunikane H, Nakajima I, Inoue K, Kawakami Y: Correlation between nucleolar organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma. Cancer 70:63-68, 1992
40. Patnaik AK, Ehler WJ, MacEwen EG: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 21:469-474, 1984
41. Pich A, Chiusa L, Navone R: Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 15:1319-1329, 2004
42. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18:5-14, 1986
43. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, Stillman B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326:517-520, 1987
44. Priester WA: Skin tumors in domestic animals: data from 12 United States and Canadian colleges of veterinary medicine. J Natl Cancer Inst 50:457-466, 1973
45. Pryer NK, Lee LB, Zadovaskaya R, Yu X, Sukbuntherng J, Cherrington JM, London CA: Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors. Clin Cancer Res 9:5729-5734, 2003
46. Qin LX, Tang ZY: The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 8:385-392, 2002
47. Quintero A, Alvarez-Kindelan J, Luque RJ, Gonzalez-Campora R, Requena MJ, Montironi R, Lopez-Beltran A: Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder. J Clin Pathol 59:83-88, 2006
48. Riva F, Brizzola S, Stefanello D, Crema S, Turin L: A study of mutations in the c-kit gene of 32 dogs with mastocytoma. J Vet Diagn Invest 17:385-388, 2005
49. Roels S, Tilmant K, Ducatelle R: PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. J Comp Pathol 121:13-24, 1999
50. Rothwell TL, Howlett CR, Middleton DJ, Griffiths DA, Duff BC: Skin neoplasms of dogs in Sydney. Aust Vet J 64:161-164, 1987
51. Ruschoff J: Nukleolus Organisierende Regionen (NORs) in der Pathomorphologishen Tumorodiagnostik. Fischer, Stuttgart, Germany, 1992
52. Sakai H, Noda A, Shirai N, Iidaka T, Yanai T, Masegi T: Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki-67 expression. J Comp Pathol 127:233-238, 2002
53. Scase TJ, Edwards D, Miller J, Henley W, Smith K, Blunden A, Murphy S: Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 20:151-158, 2006
54. Scholzen T, Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311-322, 2000
55. Seguin B, Leibman NF, Bregazzi VS, Ogilvie GK, Powers BE, Dernell WS, Fettman MJ, Withrow SJ: Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 218:1120-1123, 2001
56. Simoes JP, Schoning P, Butine M: Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 31:637-647, 1994
57. Takasaki Y, Deng JS, Tan EM: A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 154:1899-1909, 1981
58. Thamm DH, Vail DM: Mast cell tumors. In: Small Animal Clinical Oncology, eds. Withrow SJ, MacEwen EG, 3rd ed., pp. 261-282. WB Saunders, Philadelphia, PA, 2001
59. Trere D, Gramantieri L, Siringo S, Melchiorri C, Barbara L, Bolondi L, Derenzini M: In hepatocellular carcinoma AgNOR protein expression correlates with tumour mass doubling time. J Hepatol 24:60-65, 1996
60. Trere D, Pession A, Derenzini M: The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res 184:131-137, 1989
61. Trere D, Pession A, Montanaro L, Chieco P, Derenzini M: AgNOR protein expression and tumor growth rate of human carcinoma xenografts growing subcutaneously in nude mice. Eur J Histochem 41 (Suppl 2): 153-154, 1997
62. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, Galli SJ: Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A 88:6382-6386, 1991
63. van Diest PJ, Brugal G, Baak JP: Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 51:716-724, 1998
64. van Diest PJ, van der Wall E, Baak JP: Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol 57:675-681, 2004
65. Webster JD, Kiupel M, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V: The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41:371-377, 2004
66. Webster JD, Yuzbasiyan-Gurkan V, Kaneene JB, Miller R, Resau JA, Kiupel M: The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia 8:104-111, 2006
67. Weisse C, Shofer FS, Sorenmo K: Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 38:71-73, 2002
68. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351, 1987
69. Yee NS, Paek I, Besmer P: Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. J Exp Med 179:1777-1787, 1994
70. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: Characterization of an undifferentiated malignancy as a mast cell tumor using mutation analysis in the proto-oncogene c-KIT. J Vet Diagn Invest 13:341-345, 2001
71. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Vet Pathol 39:529-535, 2002